✦ LIBER ✦

7030 Dose finding and safety analysis of inecalcitol in combination with docetaxel-prednisone regimen in hormone-refractory prostate cancer (HRPC) patients (pts)

✍ Scribed by Medioni, J.; Deplanque, G.; Maurina, T.; Ferrero, J.M.; Rodier, J.M.; Raymond, E.; Allyon, J.; Kalla, S.; Dufour-Lamartinie, J.F.; Oudard, S.

Book ID: 122983881
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 55 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71408-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

POD-11.01: Dose Finding and Safety Analy

POD-11.01: Dose Finding and Safety Analysis of Inecalcitol in Combination with Docetaxel-Prednisone Regimen in Hormone-Refractory Prostate Cancer (HRPC) Patients (PTS)

✍ J. Medioni; G. Deplanque; T. Maurina; J. Ferrero; J. Rodier; E. Raymond; J. Ally 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 150 KB

430 Dose finding of inecalcitol, a new V

430 Dose finding of inecalcitol, a new VDR agonist, in combination with docetaxel–prednisone regimen for castrate-resistant prostate cancer (HRPC) patients (pts)

✍ J. Medioni; G. Deplanque; J.M. Ferrero; T. Maurina; J.M. Rodier; E. Raymond; G. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

710 DOSE FINDING AND EFFICACY PHASE 2 ST

710 DOSE FINDING AND EFFICACY PHASE 2 STUDY OF INECALCITOL, A NEW VDR AGONIST, IN COMBINATION WITH DOCETAXEL-PREDNISONE REGIMEN FOR CASTRATION-RESISTANT PROSTATE CANCER (CRPC) PATIENTS (PTS)

✍ Medioni, Jacques; Deplanque, Gael; Maurina, Tristan; Ferrero, Jean-Marc; Rodier, 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 150 KB

Phase II randomised trial of docetaxel (

Phase II randomised trial of docetaxel (D), estramustine (E) and prednisone (P) — Two schedules — versus mitoxantrone (M) and prednisone in patients (PTS) with hormone refractory prostate cancer (HRPC)

✍ S. Qudard; E.B. Banu; E. Voog; H. Hardy-Bessard; C. Linassier; P. Beuzeuboe; A. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

211 POSTER Results of a phase II study o

211 POSTER Results of a phase II study of picoplatin with docetaxel and prednisone in chemotherapy-naive patients with metastatic hormone refractory prostate cancer (HRPC)

✍ R. DeJager; L. Roman; N. Lopatkin; P. Karlov; H.B. Breitz; R. Earhart 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Early results of a multicenter phase 2 s

Early results of a multicenter phase 2 study: Weekly docetaxel and intermittent estramustin as combination chemotherapy in patients with hormone-refractory prostate cancer (HRPC)

✍ U. Steiner; K. Miller; S. Machtens; B. Backhaus; M. Siegsmund 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 226 KB